Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Reducing Time to VWD Diagnosis Improves Outcomes

Haemophilia; ePub 2017 Jun 21; Sidonio, et al

Reducing the time to von Willebrand disease (VWD) diagnosis would likely improve outcomes, according to a study involving more than 32,000 individuals. Investigators looked at how diagnosis and diagnostic delay impacted outcomes in participants with VWD, including those newly-diagnosed. Among the results:

  • Most bleeding symptoms were managed by a hospitalist/emergency room physician before diagnosis.
  • VWD misrecognition was common; one-fourth of patients visited the same kind of specialist at least twice for a bleeding episode pre-diagnosis.
  • 37% of patients had no diagnostic laboratory test within 24 months of their initial diagnosis.
  • 41% of women had bleed claims pre-diagnosis, compared with 21% post-diagnosis.
  • Pre- and post-diagnosis bleed claims in men were 26% and 9%, respectively.
  • Proportion of patients with multiple bleed claims also decreased before and after diagnosis.
  • Regularly misrecognized patients continued to have more bleeding episodes, though less frequently than before diagnosis.

Citation:

Sidonio R, Haley K, Fallaize D. Impact of diagnosis of von Willebrand disease on patient outcomes: Analysis of medical insurance claims data. [Published online ahead of print June 21, 2017]. Haemophilia. doi:10.1111/hae.13292.